Posterino GS, Dunn SL, Botting KJ, Wang W, Gentili S, Morrison JL. Changes in cardiac troponins with gestational age explain changes in cardiac muscle contractility in the sheep fetus.
-The development of the adult cardiac troponin complex in conjunction with changes in cardiac function and cardiomyocyte binucleation has not been systematically characterized during fetal life in a species where maturation of the cardiomyocytes occurs prenatally as it does in the human. The aim of this study was to correlate the expression of each of the major adult troponin isoforms (T, I, and C) during late gestation (term of 150 days) to changes in both Ca 2ϩ sensitivity and maximum Ca 2ϩ -activated force of the contractile apparatus and the maturation of cardiomyocytes. The percentage of mononucleated cardiomyocytes in the right ventricle decreased with gestational age to 46% by 137-142 days of gestation. The length of binucleated cardiomyocytes did not change with gestational age, but the length of binucleated cardiomyocytes relative to heart weight decreased with gestational age. There was no change in the expression of adult cardiac troponin T with increasing gestation. The contractile apparatus was significantly more sensitive to Ca 2ϩ at 90 days compared with either 132 or 139 days of gestation, consistent with an ϳ30% increase in the expression of adult cardiac troponin I between 90 and 110 days of gestation. Maximum Ca 2ϩ -activated force significantly increased from 90 days compared with 130 days consistent with an increase of ϳ40% in cardiac troponin C protein expression. These data show that increased adult cardiac troponin I and C protein expression across late gestation is consistent with reduced Ca 2ϩ sensitivity and increased maximum Ca 2ϩ -activated force. Furthermore, changes in cardiac troponin C, not I, protein expression track with the timing of cardiomyocyte binucleation.
heart; calcium THE TRANSITION FROM INTRAUTERINE to extrauterine life results in abrupt changes to the cardiovascular system including changes in circulation, cardiac flow, cardiac output, and blood pressure at birth. Consequently, for the heart, the force-generating capacity of the cardiomyocyte must change rapidly during gestation to meet changing demands that will occur at birth as the heart undergoes a transition towards left ventricular (LV) dominance. Changes in the force-generating capacity of cardiomyocytes during gestation have been correlated with important changes in protein expression and architecture within the excitation-contraction-relaxation (E-C-R) coupling system in rodents (28, 40, 46) but not in a species where cardiomyocyte maturation occurs before birth as it does in humans (48) . The timing of this maturation is important because mononucleated cardiomyocytes contribute to heart growth by hyperplasia, while binucleated cardiomyocytes contribute to heart growth by hyerptrophy (5, 13) . Thus in the human and sheep heart the majority of cardiomyocytes that will be in the heart for life are present at birth (47) , whereas in the rat or mouse binucleation of cardiomyocytes occurs after birth (17, 42) .
E-C-R coupling broadly describes the sequence of events from the spread of the action potential at the surface membrane to activation of calcium (Ca 2ϩ ) release from the sarcoplasmic reticulum, muscle contraction, and Ca 2ϩ uptake by the sarcoplasmic reticulum (3). The tropomyosin-troponin complex tightly regulates the development of force by the contractile apparatus. Following the release of Ca 2ϩ from the sarcoplasmic reticulum, Ca 2ϩ binds to troponin C causing a conformational change that allows the movement of tropomyosin away from the myosin binding sites on actin (36, 14, 33) . Troponin T and I are thought to influence the Ca 2ϩ sensitivity of the contractile apparatus (16, 47) , while troponin C is considered the master switch for Ca 2ϩ activation of the contractile apparatus.
During development, the transition from fetal to adult isoforms of troponin T and I, but not C, molecules have been characterized in several animal models (see Refs. 15, 40) . These transitions in protein expression, however, are rarely linked with measures of contractility, particularly in a species where cardiomyocyte binucleation (an indicator of cardiomyocyte maturation) occurs before birth, as it does in the human (48) and sheep (5) but not in mouse or rat (17, 41) . Kruger et al. (15) examined birth as a critical timing event for changes in both troponin I expression and contractile function in LV in species where binucleation occurs before (sheep and guinea pigs) and after birth (rats). They found that in rats and guinea pigs the ratio of fetal to adult isoforms of troponin I decreased throughout gestation, and furthermore, they showed that this coincided with a reduction in Ca 2ϩ sensitivity in the heart. Changes in cardiac troponin T and C and both maximum Ca 2ϩ -activated force and Ca 2ϩ sensitivity with gestational age were not examined in the sheep, a species where cardiomyocyte maturation occurs before birth and thus is more similar to the human pattern of development.
We (43) previously examined both maximum force and Ca 2ϩ sensitivity of the contractile apparatus of the right ventricle (RV) from sheep at two ages in late gestation and observed little change in either parameter. This may reflect the fact that the changes in Ca 2ϩ sensitivity and maximum Ca 2ϩ -activated force and associated protein expression may arise earlier in gestation. In rats, a significant decrease in the Ca 2ϩ sensitivity and an increase in maximum Ca 2ϩ -activated force production of cardiomyocytes occur after birth from days 7 to adult (40) , which represents the period of transition from only mononucleated cardiomyocytes to binucleated cardiomyocytes (17, 42) . This period is similar to the last third of gestation in sheep, when the transition from mononucleated to binucleated cardiomyocytes occurs, and suggests that the timing of changes troponin expression, cardiomyocyte function, and nucleation state may be linked.
Therefore, the aim of this study was to characterize the timing of expression of adult isoforms of troponin I, T, and C and relate these changes to functional outcomes and the timing of maturation using the sheep as a model of human development. Both Ca 2ϩ sensitivity and maximum Ca 2ϩ -activated force were measured in small bundles of chemically skinned RV muscle from fetal sheep across late gestation (age: 90 -142 days: term ϭ 150 Ϯ 3 days). The nucleation state of cardiomyocytes was also measured. We hypothesized that the Ca 2ϩ sensitivity of the contractile apparatus would decrease as a function of increasing adult troponin I and T and that maximum Ca 2ϩ -activated force would increase with increasing troponin C expression and that changes in protein expression will correlate with cardiomyocyte maturity.
MATERIALS AND METHODS
All experiments were performed according to guidelines of both the University of Adelaide and the University of South Australia Animal Ethics Committees.
Experimental Protocol
Selection of gestational age groups. Burrell et al. (5) and Jonker et al. (13) have shown that before 100 days of gestation all cardiomyocytes in the heart of the sheep fetus are mononucleated but that after 110 days of gestation binucleation of cardiomyocytes begins. Therefore, we chose a gestational age when all cardiomyocytes were mononucleated (90 days) and then gestational ages when the proportion of mononucleated cardiomyocytes will be decreasing (110, 119, and 130 -135 days). Term is 150 Ϯ 3 days in the Merino sheep breed (49) , and there is a prepartum surge in fetal plasma cortisol concentration after 137 days of gestation (34) . Therefore, we have studied hearts from the late gestation sheep fetus before (130 -135 days) and after (137-142 days) the start of the prepartum cortisol surge.
Animals and surgery. Fifty-two pregnant South Australian Merino ewes were utilized in this study. In the 29 animals where tissue was collected after 110 days of gestation, surgery was performed at 110 -125 days of gestation under aseptic conditions with general anesthesia induced by sodium thiopentane (1.25 g Pentothal; Rhone Merieux, Pinkenba, Australia) and maintained by inhalation of halothane (2.5-4%) in oxygen. Briefly, vascular catheters (Critchley Electrical Products, Silverwater, Australia) were inserted as previously described in the maternal jugular vein, the fetal femoral and carotid arteries, the jugular vein, and the amniotic cavity (6, 26, 27, 43) . Fetal catheters were exteriorized through a small incision in the ewe's flank. At surgery, antibiotics were administered to the ewe (153.5 mg Procaine penicillin, 393 mg benzathine penicillin, and 500 mg dihydrostreptomycin; Lyppards, Adelaide, Australia) and fetus (150 mg Procaine penicillin, 112.5 mg benzathine penicillin, and 250 mg dihydrostreptomycin; Lyppards). Antibiotics were administered intramuscularly to each ewe for 3 days after surgery and to each fetus intraamniotically (500 mg ampicillin; Lyppards) for 4 days after surgery. Animals were allowed to recover from surgery for Ն4 days before experimentation. Fetal blood samples were taken three times per week to monitor fetal health.
Tissue collection. At a range of gestational ages (90 -142 days), ewes (n ϭ 52) were humanely killed with an overdose of sodium pentobarbitone (25 ml; 325 mg/ml; Vibrac, Peakhurst, Australia) and fetuses were delivered by hysterotomy, weighed, and decapitated. Heparin (20,000 IU in 10 ml saline) followed by saturated KCl (10 ml) was perfused through the coronary vessels via the aorta (26, 27, 43) . The fetal heart was dissected and weighed, and a consistent section of ventricular tissue was flash frozen in liquid nitrogen and stored at Ϫ80°C for protein analysis. Sections of ventricle were dissected in oxygenated Tyrode's buffer and used for cardiomyocyte dissociation and further dissected for force measurements.
Cardiomyocyte dissociation. As previously described (26, 44, 45) , fetal hearts were suspended in a Langendorf apparatus and perfused through the aorta with warmed (37°C), oxygenated Tyrode's buffer with a heating pump (Paratherm II; Julabo, Schwarzwald, West Germany) using a Minipulse 3 pump (Gilson, Villeirs, France) to clear blood from the coronary vessels. Collagenase (120 U/ml; lot no. X3M6745; Worthington Biochemical, Lakewood, NJ) and protease (10 mg/200 ml; lot no. 083K0799; Sigma, Castle Hill, Australia) solution was perfused then to digest the extracellular matrix. Approximately 300 ml of Kraftbrühe buffer was then perfused through the heart to flush out these enzymes. The entire RV free wall and the septum was dissected and placed in Falcon tubes with Kraftbrühe buffer and triturated, and cardiomyocytes were collected. Cardiomyocytes were fixed in a 1% paraformaldehyde solution for storage.
Cardiomyocyte Characterization
Percentage of mononucleated cardiomyocytes. Nuclei of fixed cardiomyocytes were stained with methylene blue. The percentage of mononucleated cardiomyocytes was determined in each ventricle from each fetus by counting the number of mononucleated cardiomyocytes in a total of 200 cardiomyocytes (4, 5) using an Olympus VANOX-T microscope (Olympus Optical, Tokyo, Japan). Counters were blinded and inter-and intraobserver variability were Ͻ10%.
Hypertrophic cardiomyocyte growth. Ten microliters of fixed cardiomyocytes were stained with 1 l of 1% methylene blue on a slide and visualized with an Olympus VANOX-T microscope (Olympus Optical), and images were captured with an Olympus C-35AD-4 camera (Olympus Optical). From these images, length and area measurements (2, 9, 26, 44, 45) were made of 50 mononucleated and 50 binucleated cardiomyocytes (1) using AnalySIS software (Soft Imaging System, Adelaide, Australia) calibrated using a gradicule to 2 m and a mean determined for each animal. The length of the cardiomyocyte was the longest distance from one tip of the cardiomyocyte to the other, and the width was across the midline of the nucleus in mononucleated cardiomyocytes and midway between the two nuclei in binucleated cardiomyocytes. Inter-and intraobserver variability were Ͻ5%.
Cardiac Contractility Studies
Bundle isolation. While they were under a dissecting microscope, small bundles of cardiomyocytes of 70 -300 m diameter were isolated from the RV muscle and then attached to a force transducer (AE801 Memscap) and stationary pin by use of fine suture silk. The bundle was then briefly immersed in a high-EGTA physiological solution (solution 1; see below) to ensure that the bundle was fully relaxed. In some skinned preparations, we determined that stretching bundles by 130% of the resting length resulted in the production of optimum force to Ca 2ϩ activation consistent with the approach of other studies (29) . The bundle was then stretched by 20% of its slack length, which produced ϳ90% of optimum maximum Ca 2ϩ -activated force. Bundles were then skinned in 2% Triton X-100 for 20 min (43 , and the pH and osmolality were 7.10 Ϯ 0.01 and 295 mosmol/kg, H2O, respectively.
All bundles were chemically skinned in solution 1 containing 2% Triton-X 100 for 30 min. This procedure destroys all membranes, leaving only the contractile apparatus intact. A bundle was then washed in fresh solution 1 for 5 min and then equilibrated in a weakly buffered (2 mM) EGTA solution by combining proportions of solutions 1 and 3. The force-pCa relationship was then determined by activating the bundle in solutions of increasing free Ca 2ϩ , created by combining solutions 1 and 2 in various ratios (pCa ϭ log10[Ca 2ϩ ]; 7.3 to 5.5); the precise pCa in each activation ratio was subsequently measured by using an Orion Ca 2ϩ -sensitive electrode. Bundles were maximally activated by exposure to solution 2 (pCa ϳ4.5). The maximum Ca 2ϩ -activated force responses in bundles were normalized to the cross-sectional area of the bundle (mN/mm 2 ) for comparison. Cross-sectional area was determined by the equation area d 2 /4, assuming the muscle bundle had a cylindrical form and taking the average diameter at three locations across the fiber bundle. Submaximal force relative to the maximum Ca 2ϩ -activated force was used in determination of the force-pCa relationship. For each fiber bundle, the relative force produced for each free [Ca 2ϩ ] was plotted by use of GraphPad Prism v4.01 (GraphPad Software, San Diego, CA) and a sigmoidal dose-response curve Hill equation as follows:
Parameters Max (pCa 4.5) and Min (pCa 7.0) of the fitted curve were set to 100 and 0%, respectively. From each resulting curve the pCa required to produce 50% (pCa 50) of maximum Ca 2ϩ -activated force and the Hill coefficient (nH) were measured and averaged as reported in previous studies (43) .
Protein Expression
Western blots were performed using the Invitrogen NuPage BisTris electrophoresis system (19) . Briefly, diluted ventricular proteins (10 ug/lane) were mixed with NuPage sample buffer and heated at 70°C for 10 min then quenched on ice. Samples were loaded onto NuPAGE 12% gradient Bis-Tris gels and electrophoresed at 140 V for 1 h with MES SDS running buffer (Invitrogen, Victoria, Australia). Proteins were transferred to PVDF membranes (Perkin-Elmer Life Sciences, Boston, MA) using the Xcell Surelock electrophoresis and transfer apparatus (Invitrogen). Membranes were blocked using Trisbuffered saline with 0.1% Tween-20 ϩ 5% skim milk powder for 1 h at room temperature. Primary antibodies for adult cardiac isoforms of troponins C, T, and I (Abcam, Cambridge, MA) diluted to 1:5,000
were incubated on blots overnight at 4°C. The next day, membranes incubated with a horse anti-mouse horseradish peroxidase-conjugated secondary antibody (Cell Signalling Technology) at 1:2,000 for 1 h at room temperature, followed by band visualization using ECL. Band densities were calculated using Quantity One software (Bio-Rad Laboratories, Hercules, CA), relative to internal controls. The assumption was made that the amount of protein present was proportional to the band density.
Statistical analyses. All data are presented as means Ϯ SE. A probability value of 5% (P Ͻ 0.05) was considered significant. Unless otherwise stated, comparisons between groups were analyzed for statistical significance with either a Student's unpaired t-test or a one-way ANOVA followed by Bonferroni's multiple comparison post hoc tests, where appropriate. Table 1 shows the mean change in fetal phenotypic growth parameters across the five gestational age groups examined. All parameters showed an expected significant increase with gestational age (4 -6) with the exception of relative brain weight (not shown) and relative heart weight that showed a decrease as previously described (4 -6). Fetal heart weight increased seven fold across late gestation (Fig. 1A) .
RESULTS

Fetal Growth Characteristics
Cardiomyocyte Characteristics
We examined the change in fetal cardiomyocyte phenotypic properties across the second half of gestation to determine critical timing events that may be related to changes in other parameters (such as force and protein expression, see below). Figures 1B shows that the length of binucleated cardiomyocytes does not change with increasing gestational age and that cardiomyocytes in the RV are longer than in the LV. Relative length of both binucleated cardiomyocytes (see Fig. 1C ; 110 -113 vs. 136 -142 days) significantly decreased by 60%. Figure 2 shows the change in the percentage of mononucleated cardiomyocytes with gestational age. By late gestation, the percentage of mononucleated cardiomyocytes is ϳ50% with the greatest transition to binucleated cardiomyocytes occurring between 119 and 130 -135 days of gestation (Fig. 2B) . There is no difference between the LV and RV in the decline in the percentage of mononucleated cardiomyocytes or in the increase in the percent of binucleated cardiomyocytes. There were no cardiomyocytes with more than two nuclei.
Adult Cardiac Troponin Protein Expression
Given that the transition from mononucleated to binucleated cardiomyocytes appears to occur predominantly before 130 -135 days of gestation, we sought to examine if this transition is related to changes in adult troponin isoforms. Figure 3 , A-C, shows the mean data for the adult troponin isoform protein expression across middle to late gestation age groups. Troponin T did not show a significant change in protein expression across gestational age being clearly expressed at 90 days of gestation. Troponin I showed a two-to threefold increase between 90 days of gestation and 137-142 days. However, there was a marked increase (ϳ 2 fold) in troponin C after 119 days of gestation. There was a significant but weak correlation between the decline in the percentage of mononucleated cardiomyocytes and troponin C protein expression (y ϭ102 Ϯ 0.7x; R 2 ϭ 0.13; P ϭ 0.04).
Changes in Ca 2ϩ Sensitivity and Maximum Ca 2ϩ -Activated Force with Gestational Age
The Ca 2ϩ sensitivity of the contractile apparatus and maximum Ca 2ϩ -activated force were determined for three gestational age ranges: 90, 130 -135, and 137-142 days. Figure 4A shows three representative force pCa relationships for the three gestational age groups examined. There was a greater Ca 2ϩ sensitivity in the 90-day fetuses compared with the 132-and 140-day fetuses, which was evident by a large leftward shift in the pCa curve compared with older gestational age groups. Figure 4B shows the mean data for all fiber bundles measured at each gestational age. There was a significant decline in pCa 50 in the 130-to 135-day and 137-to 142-day age group animals compared with the 90-day animals. After 130 days, the 1 . Changes in heart weight and length of binucleated cardiomyocytes with increasing gestation. There is a dramatic increase in fetal heart weight (A) from 90 to 137-142 days of gestation without a change in the length of bincuelated cardiomyocytes (B), the cardiomyocytes that contribute to heart growth by hypertrophy. There is a decrease in the relative length of binucleated cardiomyocytes with increasing gestational age, which reflects that the dramatic increase in heart weight is not due to an equal increase in cardiomyocyte size (C). Different letters indicate a difference between gestational age groups, while asterisk indicates a difference between ventricles.
Ca 2ϩ sensitivity appears to remain constant until birth. The Hill coefficients were significantly different between the 90-and 130-to 135-day age groups (mean 1.98 Ϯ 0.03, n ϭ 7; 1.30 Ϯ 0.03, n ϭ 5; P Ͻ 0.05). The mean Hill coefficient for the 137-142 days was 1.79 Ϯ 0.17 (n ϭ 9). These changes in Ca 2ϩ sensitivity also appeared to track changes in maximum Ca 2ϩ -activated force. Maximum Ca 2ϩ -activated force increased significantly from 90 to 130 -135 days and then remained constant across late gestation (Fig. 5) . These changes appear to correlate well with the increase in troponin C observed in late gestation (see earlier). , 132-135d (n ϭ 5), and 139 -142d (n ϭ 9) fetal cardiomyocyte bundles. P Ͻ 0.001, different letters indicate statistically significant differences between age groups by one-way ANOVA (P Ͻ 0.05, Bonferroni's multiple comparison test).
DISCUSSION
In this study, we have described the developmental changes in cardiomyocyte maturation, protein expression of troponins, and contractile function in the heart of the sheep fetus. We show for the first time that the pattern of timing of protein expression for troponin C and I, but not troponin T, may be correlated with increased contractile function. Uniquely, we have shown that the transition from the mononucleated to binucleated cardiomyocytes coincides with the rapid increase in maximum Ca 2ϩ -activated force attributed to a sudden rise in adult cardiac troponin C expression.
Cardiomyocyte Characteristics
Burrell et al. (5) and Jonker et al. (13) characterized absolute changes in fetal sheep cardiomyocyte size across a period of gestation from between 77 and 146 days. Our data also indicate that there is a decrease in the percent mononucleated cardiomyocytes, the pool of cardiomyocytes that can undergo proliferation to increase heart size. We did not find that there was an increase in the length of binucleated cardiomyocytes with increasing gestational age. When values are normalized to heart weight (6), however, relative length of binucleated cardiomyocytes decreases with gestational age (see Fig. 1 ). One could interpret from this expression of the data that heart weight increases during gestation as a result of a continuing mixture of both hyperplasia and hypertrophy since the increase in heart weight is not matched by the increase in cardiomyocyte size. This is consistent with others (13) who suggest that enlargement of binucleated cardiomyocytes plays only a small role in increasing heart weight in late gestation.
Cardiac Troponin Expression During Late Gestation
Troponin isoform switching during development has been well characterized in altricial mammals such as rats and mice. In these species, the transitions from the fetal to the adult isoforms of troponin I and T was not complete until after birth and have been previously described (8, 15, 37, 38, 39, 40) . In precocial animals such as chickens (10, 37) , sheep, and guinea pigs (15) , near fully complete expression of adult isoforms occurs before birth. Troponin T mRNA expression has been studied in the sheep heart, and only one isoform is present from 64 days of gestation (22) . Our data show that adult troponin T expression remains relatively constant from 90 to 137-142 days of gestation, suggesting that the transition to the adult isoform occurred early in development or that there is no fetal troponin T isoform in sheep. Kruger et al. (15) described changes in the expression of only troponin I over the course of mid to late gestation in sheep. They showed that slow skeletal troponin I was present in the fetal heart but not the adult heart in sheep, while cardiac troponin was present in both fetal and adult life (15) . We found that adult troponin I expression was present at 90 days gestation and increased ϳ2.3-fold by 137-142 days of gestation with most of this increase occurring by 110 days (see Fig. 3B ).
In this study, the Ca 2ϩ sensitivity of the contractile apparatus of the sheep fetus significantly decreased from 90 until 130 -135 days of gestation with no change thereafter (see Fig.  4B ). These data reflect similar changes in Ca 2ϩ sensitivity reported for other animal models with the exception that the timing of these changes, which differs principally depending on whether or not the animal is fully developed at birth or continues to develop after birth (10, 15, 21, 35, 40) . The cause of this reduction in Ca 2ϩ sensitivity with gestational age in sheep (as in this study) and for most animals appears to be explained by several current observations of reciprocal transition in the expression from fetal (slow-skeletal) to adult isoforms of cardiac troponin I (see 10, 15, 21, 35, 40) . Furthermore, the study by Meztger et al. (24) very elegantly demonstrated the significant contribution of fetal slow-skeletal troponin I to heightened Ca 2ϩ sensitivity in the neonate; using adult cardiomyocytes they showed that substitution of adult cardiac troponin I with the fetal isoform (ss troponin I) greatly increased the Ca 2ϩ sensitivity. As alluded to above, the recent study by Meztger et al. (24) shows that troponin I has a significant role in the regulation of Ca 2ϩ sensitivity in rat hearts. This may extend to a functional need associated with progressive maturation of E-C coupling with gestational age. For example, it is known that the fetal sarcoplasmic reticulum (SR) is immature (20, 25, 43, 46 ) and this appears to limit the functional contractile reserve (20) . However, the fetal heart is known to function at a higher contractile state and this is most likely explained by the heightened Ca 2ϩ sensitivity of the fetal contractile apparatus. The transition between early to late gestation from a highly Ca 2ϩ -sensitive fetal to a less sensitive adult isoform of troponin I appears necessary to allow an immature cardiomyocyte to respond to limited stimuli that evoke small Ca 2ϩ signals (e.g., SR Ca 2ϩ release) while allowing a mature cardiomyocyte to moderate force with a fully functional SR. Nevertheless, many studies, however, have implicated all three troponin molecules (C, I, and T) in the regulation of cardiomyocyte what extend all three troponin molecules contribute to the overall Ca 2ϩ sensitivity. It is evident from these studies that the modulation of Ca 2ϩ sensitivity is complex and determined by multiple protein-protein interactions and that during development transitions in each three troponin isoforms most likely determine the overall Ca 2ϩ sensitivity. Furthermore, one additional consideration should be made regarding the importance of troponin I and that is its role in Fig. 5 . Maximum Ca 2ϩ -activated force per cross-sectional area from chemically skinned fetal cardiomyocyte bundles of the right ventricle. Cardiomyocytes were derived from 3 age groups: 90d (n ϭ 10 muscle bundles), 130 -135d (n ϭ 4 muscle bundles), and 137-142d (n ϭ 8 muscle bundles). P Ͻ 0.001, different letters indicate statistically significant differences between age groups by one-way ANOVA (P Ͻ 0.05, Bonferroni's multiple comparison test).
passive force. The presence of troponin I (and troponin T) is essential to ensure that the contractile apparatus remains in relaxed state in the absence of Ca 2ϩ . Thus, during gestation, the continued high expression of troponin I (and Troponin T; whether it be the fetal or adult isoform) is necessary to ensure that the myofilaments are well regulated.
Interestingly, less is known about the developmental changes in cardiac troponin C expression, as much attention has been given to the role of troponin I and T in their role of modulating the Ca 2ϩ sensitivity. As mentioned above, the presence of troponin I is absolutely essential to ensure that the contractile apparatus remains in relaxed state in the absence of Ca 2ϩ . However, this is not necessary with respect to troponin C because in its absence the contractile apparatus cannot produce active force regardless of the intracellular Ca 2ϩ level. It is therefore, not surprising that only a single troponin C isoform has been identified in rats and that its abundance increases as shown in this study with respect to other subunits of the troponin complex as the cardiomyocytes mature. Troponin C is the major determinant of maximum Ca 2ϩ -activated force. Only a single cardiac troponin C isoform (slow TnC) is expressed in the murine heart throughout development (31, 32) with no other evidence of fetal isoform being expressed. Here we have shown for the first time that troponin C expression increases suddenly approximately twofold in late gestation (after 130 days; see Fig. 3C ) and that this coincides with an increase in maximum Ca 2ϩ -activated force (see Fig. 5 ). Such changes may be thought to be associated with increased tissue mass (myofibrillar protein) and can be related to preparation for birth in these animals. The increase in troponin C expression appears timed with the increase in the percentage of binucleated cardiomyocytes. This would suggest that the timing of troponin C expression is linked potentially to a time when cardiomyocytes would be expected to undergo a transition towards greater hypertrophy rather than hyperplasia.
Hypertrophy normally results in changes in absolute amounts of protein within the cardiomyocytes. One would expect that this would also lead to a comparable change in maximum Ca 2ϩ -activated force as cross sectional area increases but not in maximum Ca 2ϩ -activated force per crosssectional area. Previous early studies by Godt et al. (10) and Anderson et al. (1) have shown or suggested that accumulation of myofibrillar protein simply underlined the observed increased maximum force (per cross sectional area) in the chick and sheep ventricular muscle studied. Lim et al. (18) found that most of the myofibrillar protein necessary for the development of contractile force appeared very early in embryogenesis before the development of a functional sarcomeric structure, suggesting that as development occurs, changes in maximum force per cross sectional area cannot be simply attributed to myofibrillar mass. This is supported by a recent study by Seidner et al. (40) where they could not find comparable changes in a major myofibrillar protein, myosin heavy chain, and the development of maximum force. We show here that relative length of binucleated cardiomyocytes decreases with gestational age, suggesting that the observed change in maximum force per cross-sectional area may be attributed to some other variable. The most likely other variable from our results appears to simply be the increased troponin C expression, which would not contribute substantially to overall myofibrillar protein mass but in its absence would prevent the development of force when Ca 2ϩ concentration rises. That is, in early gestation, the troponin complex (the sum of normally three troponin molecules) lacks troponin C in many parts of the myofilament. In this way, the immature cardiomyocyte is able to limit maximum active force generation at a time when other parts of the E-C coupling pathway (such as SR function; Ref. 20) are still maturing in the presence of a very Ca 2ϩ -sensitive myofilament.
Conclusions
The capacity to develop force in cardiomyocytes requires that as development progresses there is a switch from high to low Ca 2ϩ sensitivity and thus an increase in capacity to develop Ca 2ϩ -activated force. Previous studies in rats and mice were confounded by the fact that binucleation occurs postnatally when the LV has higher output, unlike the human and sheep where binucleation occurs before birth when LV and RV ventricular output are equal. Our data show that troponin I protein expression increases before cardiomyocyte binucleation but that troponin C protein expression increases with binucleation of cardiomyocytes. In addition, the decrease in Ca 2ϩ sensitivity and increase in Ca 2ϩ -activated maximum force occurs after binucleation begins and when troponin C protein expression is elevated. This prepares the heart for increased demand at birth. 
